| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
20,518 |
16,938 |
$735K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,197 |
4,144 |
$330K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,596 |
3,414 |
$270K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,563 |
2,517 |
$212K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
19,150 |
8,951 |
$205K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,569 |
1,539 |
$142K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,844 |
1,762 |
$90K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,422 |
3,056 |
$82K |
| 99429 |
|
1,576 |
1,564 |
$53K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
5,354 |
3,576 |
$43K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
419 |
404 |
$22K |
| 99381 |
|
279 |
265 |
$22K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,620 |
1,578 |
$21K |
| 97802 |
|
6,701 |
6,534 |
$20K |
| 90461 |
|
6,453 |
5,408 |
$20K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
400 |
358 |
$4K |
| 96161 |
|
1,783 |
1,744 |
$4K |
| 0072A |
|
92 |
91 |
$4K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
44 |
44 |
$3K |
| 0071A |
|
55 |
55 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
26 |
25 |
$1K |
| 0001A |
|
80 |
64 |
$1K |
| 86580 |
|
100 |
98 |
$801.08 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
49 |
48 |
$686.88 |
| 0002A |
|
13 |
13 |
$520.00 |
| 97803 |
|
1,213 |
1,054 |
$446.70 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
15 |
15 |
$361.39 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
31 |
27 |
$322.28 |
| 90686 |
|
2,369 |
2,350 |
$17.52 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
50 |
49 |
$7.50 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
31 |
27 |
$1.59 |
| 90621 |
|
355 |
348 |
$0.02 |
| 90651 |
|
742 |
726 |
$0.01 |
| 90710 |
|
1,297 |
1,285 |
$0.00 |
| 90700 |
|
760 |
755 |
$0.00 |
| 91300 |
|
108 |
90 |
$0.00 |
| 90670 |
|
1,846 |
1,803 |
$0.00 |
| 90734 |
|
706 |
685 |
$0.00 |
| 90648 |
|
1,352 |
1,334 |
$0.00 |
| 90633 |
|
1,482 |
1,460 |
$0.00 |
| 90707 |
|
38 |
38 |
$0.00 |
| 90715 |
|
184 |
179 |
$0.00 |
| 90671 |
|
1,265 |
1,244 |
$0.00 |
| 90696 |
|
433 |
426 |
$0.00 |
| 90680 |
|
2,183 |
2,128 |
$0.00 |
| 90698 |
|
296 |
293 |
$0.00 |
| 90723 |
|
595 |
587 |
$0.00 |
| 90697 |
|
1,349 |
1,308 |
$0.00 |
| 91307 |
|
170 |
165 |
$0.00 |
| 90620 |
|
123 |
122 |
$0.00 |
| 90744 |
|
15 |
15 |
$0.00 |
| 90716 |
|
26 |
26 |
$0.00 |